DAFTAR PUSTAKA

1. Akib AAP, Myrna S, Budi S. Lupus Eritematosus Sistemik. Dalam: Akib AAP, Munasir Zakiudin, Kurniati N, penyunting. Buku Ajar Alergi Imunologi Anak Edisi Kedua. Jakarta: Badan Penerbit IDAI 2010; p.345-72. 2. Silverman E, Allison E. Systemic Lupus Erythematosus. In: Cassidy JT, Ronald ML, Ross EP, Carol BL (eds). Text Book Of Pediatric Rheumatology, 6th Ed. Philadelphia: Elsevier; 2011. p.315-41. 3. Gottlieb BS, Ilowite NT. Systemic Lupus Erythematosus in children and adolescents. Pediatrics in review 2006;27(9):323-9. 4. Pusongchai T, Jungthirapanich J, Khositseth S. Pediatric Systemic Lupus Erythematosus In Thammasat University Hospital. J Med Assoc Thai.2010; 93: S283-91. 5. Arbuckle MR, McClain MT, Rubertone MV, et al. Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus. N Eng J Med 2003;349:1526-33. 6. Dewi cahya, Muktiarti Dina, dkk. Lupus eritematosus sistemik. In Pedoman pelayanan medis.IDAI. edisi II.tahun 2011. Penerbit: ikatan dokter anak indonesia. Hal.175-183 7. Tsokos, George C. Mechanism of Disease Systemic Lupus Erythematosus. N Eng J Med 2011;365:2110-21. 8. Harville, Terry O. Systemic Lupus Erythematosus. In: Rudolph AM, Hoffman JIE, Rudolph CD (eds). Rudolphs Pediatrics, 20th Ed. Rudolph Pediatrics . USA: Appleton & Lange 1996; 486-9 9. Malleson, Pete dan Jenny Tekano. Diagnosis and Management of Systemic Lupus Erythematosus in Children. Journal of Pediatric and Child Health 2007;18:2. 10. Klein-Gitelman MS, Michael LM. Systemic Lupus Erythematosus. In: Kliegman RM, Bonita FS, Joseph WS, et al (eds). Nelson Text book of pediatrics19th Ed. Philadelphia: Elsevier; 2011. 11. Stichweh D, Pascual V. Systemic lupus erythematosus in children. An Pediatr(barc) 2005;63(4):319-27. 12. Chiang LL, Yu-Tsan L, Hung-Yi C, et al. Differential Manifestation of Prepubescent, Pubescent and Postpubescent Pediatric Patients with Systemic Lupus Erythematosus: A Retrospective study of 96 Chinese Children and Adolescents. Journal of pediatric Rheumatology 2012;10:12.

xi

13. Evalina R. Gambaran klinis dan kelainan imunologis pada anak dengan lupus eritematosus sistemik di rumah sakit umum pusat adam malik medan. SARI PEDIATRI 2012;13(6):406-11 14. American college of rheumatology ad hoc committee on systemic lupus erythematosus guidelines. Arthritis rheum 1999;42(9):1785-96. 15. Kalim H dkk. Diagnosis dan pengelolaan lupus eritematosus sistemik. Perhimpunan reumatologi indonesia. 2011 16. Ni Putu Sudewi,nia kurniati EM dadi suyoko, Zakiudin munasir, arwin AP Akib. Karakteristik klinis lupus eritematosus sistemik pada anak. SARI PEDIATRI 2009;11(2):108-12 17. Mok CC, Lau CS. Pathogenesis of systemic lupus erithematosus. J Clin Pathol 2003;56:481-90 18. Miettunen P, Ortiz A, Petty R, Cimaz R, Malleson P, et al. Gender and ethnic Origin have no effect on longterm outcome of childhood-onset Systemic Lupus Erythematosus. The Journal of Rheumatology 2004;31-8 19. Alatas, Husein. Nefritis Lupus. Dalam: Alatas H, Taralan T, Partini PT, et al, penyunting. Buku Ajar Nefrologi Anak Edisi Kedua. Jakarta: Balai Penerbit Fakultas Kedokteran Universitas Indonesia 2004;366-79 20. Costner M and Sontheimer R. Lupus Erythematosus. In: Wolff C, Goldsmith L, Katz S, Paller A and Leffell D. Fitzpatricks Dermatology in General Medicine, 7th Ed. USA: McGraw-Hill; 2008. p.1515-1535 21. Muchtar A dan Suyatna F. Obat antiaritmia. Dalam: buku farmakologi dan terapi. Edisi IV. Jakarta: badan penerbit Universitas Indonesia 2005;21(6):289-314. 22. Benowitz N dan Bourne H. Obat antihipertensi. Dalam: Katzung B. Farmakologi dasar dan klinik. Edisi III. Jakarta: EGC 2005;10:125-149 23. McMuray RW, Waren M. Sex Hormones and Systemic Lupus Erythematosus. Review of Arthritis and rheumatism 2003;48(8):2100-10 24. Park, Myung K. Cardiovascular involvement in systemic disease. In: Pediatric Cardiology, 5th Ed. Philadelphia: Elsevier; 2011. p.408. 25. Falcao CA, Lucena N, Alves IC, Pessoa AL, Godoi ET. Lupus Carditis. Arq Bras Cardiol 2000;74(1):p.64-71. 26. Asanuma Yu, annete O, Ayumi KS, et al. Premature Coronary Artery atherosclerosis in Systemic Lupus Erythematosus. N eng J Med 2003;349(25): p.2407-15.

xii

27. Keane, Michael P, Joseph PL. Pleuropulmonary manifestations of systemic lupus erythematosus. In: Tattersfield AE, du Bois RM (eds). Thorax international respiratory journal. 2000;55:159166. 28. Gari Abdul Ghafoor, Amr Telmesani, Raad Alwithenani. Pulmonary Manifestations of Systemic Lupus Erythematosus. In: Almoallim Hani (Ed). Systemic Lupus Erythematosus. Saudi Arabia: Umm Al-Qura University 2012. p. 314-36 29. Houssiau FA. Toward Better Treatment for Lupus Nephritis. N eng J Med 2011;365(20):p.1929-30. 30. Alatas Husein. Nefritis Lupus pada Anak. Dalam: Noer MS, Ninik AS, Krisni S, et al (penyunting). Kompendium Nefrologi anak. Jakarta: Badan Penerbit IDAI; 2011.p.118 23 31. Guzman J, Cardiel MH, Arce-salinas, et al. Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices. J Rheumatol 1992;19:1551-1558 32. Strand V, Gladman D, Isenberg D, Petri M, Tugwell P, et al. Outcome measures to be used in Clinical Trials in systemic lupus Erythematosus. The Journal of Rheumatology. 1999; 26:2:490-7 33. Hawker G, Gabriel S, Bombardier C, et al. A reliability study of SLEDAI. J Rheumatol 1993;20:657-60 34. Hochberg MC. Outcome measures in perspective: systemic lupus erythematosus. In: strand V, Johnson K, Pillemer S, editors. Proceedings: biologic agents in autoimmune disease. IV. Atlanta: arthritis foundation; 1996:147-53 35. Cervera R, espinosa G, Dcruz D. Systemic lupus erythematosus: pathogenesi s, clinical manifestation and diagnosis. In Eular compendium on rheumatic diseases. BMJ publishing group and european league against rheumatism 1st ed: 2009; 257-68 36. Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. Guideline for clinical use of the antinuclear antibody test and test for spesific autoantibody to nuclear antigen. Arch pathol lab med. 2000;124:71-81. 37. Dooley MA. Clinical and laboratory features of lupus nephritis. Wallace DJ, Hahn BH, editors. Dubois lupus erythematosus. 7th ed. Lippincott William adn Wilkins. 2007; 1112-30. 38. Buyon JP. Systemic lupus erythematosus a clinical and laboratory features in : klippel JH. Primer on the reumatic diseases. 13th ed. Atlanta: artritis foundation. 2008:303-18 39. Muslikhah yuni,sunartini hapsara, cahya dewi satria. Antibodi anti ds-DNA sebagai faktor prognosis mortalitas pada lupus eritematosus sistemik. SARI PEDIATRI 2012;14(2):90-6
xiii

40. Shyam C, Malaviya AN. Infection related morbidity in systemic lupus erythematosus: a clinico epidemiological study from northern india. Rheumatol Int 1996;16(1):1-3. 41. Feng PH, Tan TH. Tuberculosis in patients with systemic lupus erythematosus. Ann Rheum Dis 1982;41(1):11-4 42. Bertsias GK, loannidis JPA, boletis J, Bombardieri S, Cervera R, Dostal C, et al. EULAR reccomendations for the management of systemic lupus erythematosus. Report of a task force of the european standing committee for international clinical studies including therapeutics (ESCISIT). Ann rheum dis 2008;67:195-205. 43. DCruz DP, Khamashta MA, Hughes GR. Systemic lupus erythematosus. Lancet 2007; 369: 587-596 44. Guil GM, et al. Effectiveness of the treatment of systemic lupus erythematosus with methotrexate. Med Clin (Barc). 1993 Oct 2;101(10):361-4. 45. Nossence HC and Koldingsnes. Longterm efficacy of azathioprine treatment for proliferative lupus nephritis. Rheumatology (2000) 39 (9): 969-974 46. Tangnararatchakit K, et al. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children. J Med Assoc Thai. 1999 Nov;82. 47. Falcini F, et al. Mycophenolate mofetil for the treatment of juvenile onset SLE: a multicenter study. Lupus. 2009 Feb;18(2):139-43. 48. Merrill JT, et al. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind evaluation of rituximab trial. Arthritis Rheum. 2010 Jan;62(1):222-33.

xiv